fluorescein-5-isothiocyanate has been researched along with Hyperlipoproteinemia Type II in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alves, AC; Benito-Vicente, A; Bourbon, M; Etxebarria, A; Martin, C; Ostolaza, H | 1 |
Brorholt-Petersen, JU; Faergeman, O; Jensen, HK; Raungaard, B | 1 |
Agnani, G; Benhamamouch, S; Clavey, V; Fruchart, JC; Kuznierz, JP; Lecerf, JM; Marzin, D | 1 |
1 trial(s) available for fluorescein-5-isothiocyanate and Hyperlipoproteinemia Type II
Article | Year |
---|---|
Flow cytometric assessment of effects of fluvastatin on low-density lipoprotein receptor activity in stimulated T-lymphocytes from patients with heterozygous familial hypercholesterolemia.
Topics: Amino Acid Substitution; Antibodies, Monoclonal; Anticholesteremic Agents; Carbocyanines; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Data Interpretation, Statistical; Fatty Acids, Monounsaturated; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluvastatin; Heterozygote; Humans; Hyperlipoproteinemia Type II; Indoles; Lipoproteins, LDL; Mutation; Protein Binding; Receptors, LDL; T-Lymphocytes; Triglycerides | 2000 |
2 other study(ies) available for fluorescein-5-isothiocyanate and Hyperlipoproteinemia Type II
Article | Year |
---|---|
Advantages and versatility of fluorescence-based methodology to characterize the functionality of LDLR and class mutation assignment.
Topics: Animals; CHO Cells; Computer Simulation; Cricetulus; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Microscopy, Confocal; Mutation; Receptors, LDL; Transfection | 2014 |
Determination of the LDL receptor binding capacity of human lymphocytes by immunocytofluorimetric assay.
Topics: Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Hyperlipoproteinemia Type II; Immunoassay; Lipoproteins, LDL; Lymphocytes; Male; Phytohemagglutinins; Receptors, LDL; Thiocyanates | 1989 |